Merck & Co. Inc. (MRK)

$ 129.49
   
  • Change Today:
    $-1.60
  • 52 Week High: $131.95
  • 52 Week Low: $100.18
  • Currency: US Dollars
  • Shares Issued: 2,531.63m
  • Volume: 5,983,846
  • Market Cap: $327,821m
  • RiskGrade: 92

Latest ShareCast News

US close: Stocks recover from three days of losses

By Josh White

Date: Thursday 28 Mar 2024

(Sharecast News) - Shares on Wall Street showed signs of recovery on Wednesday, with all major indices edging higher amidst low trading volumes following three consecutive down sessions.

US close: Stocks bounce back as labour market softens

By Josh White

Date: Friday 02 Feb 2024

(Sharecast News) - Wall Street equities experienced a notable rebound on Thursday, bouncing back from a significant sell-off in the previous session.

Moderna shares surge on cancer trial combo with Merck treatment

By Frank Prenesti

Date: Thursday 14 Dec 2023

(Sharecast News) - Shares in Moderna surged on Thursday after trial results of its experimental cancer vaccine, used in conjunction with Merck's Keytruda treatment, reduced the risk of death or relapse in patients with the most deadly form of skin cancer after three years.

Merck to buy Caraway Therapeutics for up to $610m 21-Nov-2023 ShareCast
Merck beats on Q1 earnings amid 'strong underlyi... 27-Apr-2023 ShareCast
Merck & Co. posts stronger-than-expected Q4 numb... 02-Feb-2023 ShareCast
Moderna Covid vaccine sales top $18bn 09-Jan-2023 ShareCast
FDA gives AstraZeneca extension on cancer drug a... 15-Dec-2022 ShareCast
Merck to buy Imago BioSciences in $1.35bn deal 21-Nov-2022 ShareCast
Merck afirma que las prescripciones para el Covi... 03-Feb-2022 ShareCast
Merck beats Q4 forecasts amid broad jump in sales 03-Feb-2022 ShareCast
Merck&Co. says oral Covid-19 treatment cuts risk... 26-Nov-2021 ShareCast
Merck and Ridgeback file with FDA for emergency ... 11-Oct-2021 ShareCast
Merck and Ridgeback report good results in trial... 01-Oct-2021 ShareCast
Merck starts third phase clinical trial to evalu... 01-Sep-2021 ShareCast
AstraZeneca, MSD prostate cancer drug gets China... 24-Jun-2021 ShareCast
US government to spend $1.2bn on Merck Covid drug 09-Jun-2021 ShareCast
Merck to buy Pandion Therapeutics for $1.85bn 25-Feb-2021 ShareCast
AstraZeneca's breast cancer drug moves to early ... 17-Feb-2021 ShareCast
AstraZeneca's Lynparza cancer drug approved by J... 29-Dec-2020 ShareCast
 

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Merck Market Data

Currency US Dollars
Share Price $ 129.49
Change Today $ -1.60
% Change -1.22 %
52 Week High $131.95
52 Week Low $100.18
Volume 5,983,846
Shares Issued 2,531.63m
Market Cap $327,821m
RiskGrade 92

What The Brokers Say

Strong Buy 11
Buy 11
Neutral 3
Sell 0
Strong Sell 0
Total 25
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Trades for 24-May-2024

Time Volume / Share Price
16:00 1,103,700 @ $129.49
15:59 100 @ $129.48
15:59 313 @ $129.48
15:59 100 @ $129.48
15:59 100 @ $129.53

Top of Page